Clinical Trials Directory

Trials / Completed

CompletedNCT00232869

A Study of the SMART Stent in the Treatment SFA Disease.

A Clinical Investigation of the SIROlimus Coated Cordis SMART™ Nitinol Selfexpandable Stent for the Treatment of Obstructive Superficial Femoral Artery Disease.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
93 (actual)
Sponsor
Cordis US Corp. · Industry
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to assess the safety and performance of the sirolimus coated Cordis SMART™ nitinol self expandable stent device and its delivery system in the treatment of obstructive superficial femoral artery (SFA) disease in reducing percent in-stent mean lumen diameter stenosis in de novo or restenotic native lesions as compared to the uncoated SMART™ stent.

Detailed description

This is a multi-center, prospective, randomized, double blind, two-arm feasibility study evaluating the safety and performance of the sirolimus coated Cordis SMART™ nitinol self-expanding stent and delivery system as compared to the uncoated SMART™ stent and delivery system. It is anticipated that a total of 90 patients will be entered into the study. Patients will be randomized on a 1:1 basis of coated to uncoated stents. Ninety (90) patients with de novo or restenotic native SFA lesions will be randomized to the Sirolimus Coated SMART™ nitinol self-expanding stent or to the uncoated (bare) SMART™ stent. Patients will be followed for 24 months post-procedure, with all patients having duplex ultrasound and clinical assessments at discharge, 1, 6, 9, 18 and 24 months, angiography at 6 six months and plain X-ray at 18 months. This study will be conducted at nine investigational sites. (Protocol was amended where 56 additional patients were recruited and followed for up to 5 years.)

Conditions

Interventions

TypeNameDescription
DEVICEdrug-eluting stentSirolimus Coated Cordis SMART™ nitinol selfexpandable stent
DEVICEbare-metal stentSMART™ bare-metal stent

Timeline

Start date
2001-02-01
Primary completion
2003-06-01
Completion
2009-05-01
First posted
2005-10-05
Last updated
2010-02-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00232869. Inclusion in this directory is not an endorsement.